Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3864

Sort by

Sort Order Select

Journal Articles

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Blood blood.2024025536.

https://doi.org/10.1182/blood.2024025536

Published: 2025

Includes: Supplemental data

Journal Articles

Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death

Anastasia M. Frank-Kamenetskii, Hannah Klinghoffer, Jemy Anna Varghese, Vinh Dang, Jeremy Morrissette, Joseph A. Fraietta, Caroline Diorio, Janis K. Burkhardt, Scott Canna

Blood blood.2024027179.

https://doi.org/10.1182/blood.2024027179

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

The JAK2 46/1 haplotype influences PD-L1 expression

Gonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, Alejandra Leivas, Jesús Victorino, Roberto García-Vicente, Andrew J. Chase, Andrea Maidana, William J. Tapper, Rosa Ayala, Nicholas C. P. Cross, Joaquín Martínez-López, Miguel Manzanares

Blood (2025) 145 (19): 2196–2201.

https://doi.org/10.1182/blood.2023023787

Published: 2025

Includes: Supplemental data

Journal Articles

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease

Julie R. Boiko, Kathleen S. Ensbey, Olivia G. Waltner, Isaac C. Jenkins, Shruti S. Bhise, Kelli P. A. MacDonald, Bruce R. Blazar, A. Marcie Hall, Ted A. Gooley, Simone A. Minnie, Stephanie J. Lee, Scott N. Furlan, Geoffrey R. Hill

Blood (2025) 145 (19): 2214–2228.

https://doi.org/10.1182/blood.2024025337

Published: 2025

Includes: Supplemental data

Journal Articles

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia

Andreas Linder, Daniel Nixdorf, Niklas Kuhl, Ignazio Piseddu, TengTeng Xu, Anne V. Holtermann, Gunnar Kuut, Rebekka Endres, Nora Philipp, Veit Bücklein, Johann de Graaff, Thomas Carell, Sebastian Kobold, Roman Kischel, Veit Hornung, Marion Subklewe

Blood (2025) 145 (19): 2149–2160.

https://doi.org/10.1182/blood.2024026934

Published: 2025

Includes: Supplemental data

Journal Articles

Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface

Zohreh Mansoori Moghadam, Bei Zhao, Candice Raynaud, Valentina Strohmeier, Jana Neuber, Anne Kathrin Lösslein, Sabrina Qureshi, Vitka Gres, Tara Ziegelbauer, Sebastian Baasch, Christoph Schell, Klaus Warnatz, Naohiro Inohara, Gabriel Nuñez, Thomas Clavel, Stephan P. Rosshart, Julia Kolter, Philipp Henneke

Blood (2025) 145 (18): 2025–2040.

https://doi.org/10.1182/blood.2024025240

Published: 2025

Includes: Supplemental data

Journal Articles

Donor regulatory T-cell therapy to prevent graft-versus-host disease

Blood (2025) 145 (18): 2012–2024.

https://doi.org/10.1182/blood.2024026446

Published: 2025

Includes: Supplemental data

Journal Articles

CAR T cells in autoimmunity: game changer or stepping stone?

Dimitrios Mougiakakos, Everett H. Meyer, Georg Schett

Blood (2025) 145 (17): 1841–1849.

https://doi.org/10.1182/blood.2024025413

Published: 2025

Includes: Supplemental data

Journal Articles

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia

Blood (2025) 145 (17): 1943–1956.

https://doi.org/10.1182/blood.2024026886

Published: 2025

Includes: Supplemental data

Journal Articles

Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma

Cameron S. Lewis, Allison Barraclough, Eliza A. Hawkes

Blood (2025) 145 (17): 1850–1857.

https://doi.org/10.1182/blood.2024025772

Published: 2025

Journal Articles

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood blood.2025028833.

https://doi.org/10.1182/blood.2025028833

Published: 2025

Includes: Supplemental data

Journal Articles

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30 + lymphoma

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández, Rosanna Montserrat-Torres, Maria Guardiola-Perello, Eva Escudero-López, Irene Garcia-Cadenas, Albert Esquirol, Rodrigo Martino, Paola Jara-Bustamante, Pol Ezquerra, José Manuel Soria, Eva Iranzo, Maria-Estela Moreno-Martinez, Mireia Riba, Jorge Sierra, Carmen Alvarez-Fernández, Laura Escribà-Garcia, Javier Briones

Blood (2025) 145 (16): 1788–1801.

https://doi.org/10.1182/blood.2024026758

Published: 2025

Includes: Supplemental data

Journal Articles

Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes

Blood (2025) 145 (15): 1645–1657.

https://doi.org/10.1182/blood.2024024965

Published: 2025

Includes: Supplemental data

Journal Articles

How I Treat Wiskott-Aldrich syndrome

Tanja C Vallée, Michael H Albert, Sung-Yun Pai

Blood blood.2024026288.

https://doi.org/10.1182/blood.2024026288

Published: 2025

Includes: Supplemental data

Journal Articles

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen, Sofia Forstén, Essi Laajala, Diogo Dias, Shady Adnan-Awad, Aleksandr Ianevski, Jay Klievink, Hanna Lähteenmäki, Heikki Kuusanmäki, Mikko Myllymäki, Tiina Kasanen, Khalid Saeed, Dean A. Lee, Henrik Hjorth-Hansen, Tero Aittokallio, Olli Dufva, Satu Mustjoki

Blood (2025) 145 (15): 1670–1686.

https://doi.org/10.1182/blood.2024025286

Published: 2025

Includes: Supplemental data

Journal Articles

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Joshua D. Brody, Judit Jørgensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David John Lewis, Yasmin H. Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Aqeel Abbas, Liwei Wang, Malene Risum, Raul Cordoba

Blood (2025) 145 (15): 1621–1631.

https://doi.org/10.1182/blood.2024026830

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance

Blood (2025) 145 (15): 1687–1700.

https://doi.org/10.1182/blood.2024025884

Published: 2025

Includes: Supplemental data

Journal Articles

Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis

Blood blood.2024026216.

https://doi.org/10.1182/blood.2024026216

Published: 2025

Includes: Supplemental data

Journal Articles

Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Sara K Silbert, Alexander W Rankin, Chloe N Hoang, Alexandra Semchenkova, Regina M Myers, Elena Zerkalenkova, PhD, Hao-Wei Wang, Alexandra E Kovach, Constance M Yuan, Dana Delgado Colon, Loic Vasseur, Alex Bataller, Samuel John, Kaylyn Utley Lyons, Barbara D. Friedes, Anna Alonso-Saladrigues, Hisham Abdel-Azim, Estelle Balducci, Ahmed Aljudi, Marie Balsat, D. Nathan Biery, Aghiad Chamdin, Bill H Chang, Raymund S Cuevo, MD, Barbara De Moerloose, David S. Dickens, Ulrich A Duffner, Nicolas Duployez, Firas El Chaer, Michelle Ann Elliott, Gabriele Escherich, Sneha Fernandes, Mandi R Fitzjohn, Zhubin J Gahvari, Stephan A. Grupp, Rui Rochelle He, M.D., Cynthia Harrison, Christopher Bruce Hergott, Emily M. Hsieh, Annette S Kim, Dennis John Kuo, Daniel P Larson, Benjamin J Lee, Thibaut TL Leguay, R. Coleman Lindsley, Abhishek A. Mangaonkar, Kerstin Mezger, Holly L Pacenta, Jing Pan, Marlie R. M. Provost, Latika Puri, Sunil Sudhir Raikar, Armando Jose Martinez, Isabella Quijada Bristol, Kyle Daniel Murphy, Lauren Reiman, Michele S Redell, Kelly Reed, Gabrielle Roth Guepin, Jeremy D Rubinstein, Süreyya Savaşan, Kristian T Schafernak, Alexandra McLean Stevens, Aimee C Talleur, Naomi Torres Carapia, Jacques Vargaftig, Anant Vatsayan, Matthias Wölfl, Lipng Zhao, Susana Rives, Vanessa A. Fabrizio, Koji Sasaki, Ibrahim Aldoss, Nicolas Boissel, Susan R Rheingold, Kara L Davis, Sara Ghorashian, Elad Jacoby, Alexander Popov, Adam Joseph Lamble, Nirali N Shah

Blood blood.2024026655.

https://doi.org/10.1182/blood.2024026655

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Blood (2025) 145 (14): 1526–1535.

https://doi.org/10.1182/blood.2024026401

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death

The JAK2 46/1 haplotype influences PD-L1 expression

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia

Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface

Donor regulatory T-cell therapy to prevent graft-versus-host disease

CAR T cells in autoimmunity: game changer or stepping stone?

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia

Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30 + lymphoma

Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes

How I Treat Wiskott-Aldrich syndrome

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance

Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis

Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only